Avenda Health
Avenda Health's Unfold AI is an FDA-cleared platform that uses AI to map prostate cancer in 3D, providing personalized cancer estimation maps and aiding in treatment decisions for urologists.
Services
Avenda Health provides Unfold AI, an AI-based platform that maps prostate cancer in 3D to offer a personalized cancer estimation map for each patient. This service includes the integration of patient-specific data, such as MRI, PSA, biopsy, and pathology, to characterize prostate cancer. The platform is tailored for patients diagnosed with Gleason Grade 2 (GG2) or greater who have not begun prostate cancer treatment. Unfold AI assists in surgical planning, guides repeat biopsies, determines the extent of needed prostate treatment, and focuses radiation areas for radiotherapy.
FDA Clearance and Clinical Validation
Unfold AI has received FDA clearance under the designation K221624. Clinically, it has demonstrated a superior sensitivity of 97% at detecting prostate cancer. The tool has influenced treatment recommendations from urologists 28% of the time. Validated through multiple clinical studies, Unfold AI offers improved accuracy in determining the location and scope of prostate cancer compared to existing methods.
Integration and Partnerships
Avenda Health’s Unfold AI integrates seamlessly with PrecisionPoint®, aiming to redefine patient outcomes in the field of urology. The company is also collaborating with BioscienceLA to establish a new life sciences innovation hub in the United States. These integrations and partnerships highlight Avenda Health’s commitment to bringing cutting-edge AI technology to the forefront of prostate cancer treatment.
Recognition and Commercial Use
Unfold AI has achieved a landmark Category III CPT Code designation, being the first and only AI-based prostate cancer decision support platform. The technology was featured on NBC News during President Biden’s AI Forum held in San Francisco, marking its significant impact in the healthcare sector. Additionally, Avenda Health announced the first commercial use of Unfold AI on prostate cancer patients in the United States.
Mission and Goals
Avenda Health's mission is to create a more personalized future in prostate cancer care through the application of deep learning technologies. The company focuses on improving patient outcomes, preserving quality of life, and setting a new standard of care in cancer treatment. Avenda Health is dedicated to making advanced AI tools accessible to all practices and physicians involved in prostate cancer care.